SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer.

Mol Cell
Authors
Keywords
Abstract

Oncogenic mutations in PIK3CA, the gene encoding the catalytic subunit of phosphoinositide 3-kinase (PI3K), occur with high frequency in breast cancer. The protein kinase Akt is considered to be the primary effector of PIK3CA, although mechanisms by which PI3K mediates Akt-independent tumorigenic signals remain obscure. We show that serum and glucocorticoid-regulated kinase 3 (SGK3) is amplified in breast cancer and activated downstream of PIK3CA in a manner dependent on the phosphoinositide phosphatase INPP4B. Expression of INPP4B leads to enhanced SGK3 activation and suppression of Akt phosphorylation. Activation of SGK3 downstream of PIK3CA and INPP4B is required for 3D proliferation, invasive migration, and tumorigenesis in vivo. We further show that SGK3 targets the metastasis suppressor NDRG1 for degradation by Fbw7. We propose a model in which breast cancers harboring oncogenic PIK3CA activate SGK3 signaling while suppressing Akt, indicative of oncogenic functions for both INPP4B and SGK3 in these tumors.

Year of Publication
2014
Journal
Mol Cell
Volume
56
Issue
4
Pages
595-607
Date Published
2014 Nov 20
ISSN
1097-4164
URL
DOI
10.1016/j.molcel.2014.09.023
PubMed ID
25458846
PubMed Central ID
PMC4255362
Links
Grant list
U54 CA143798 / CA / NCI NIH HHS / United States
GM094777 / GM / NIGMS NIH HHS / United States
R01 GM094777 / GM / NIGMS NIH HHS / United States
K01 AG041218 / AG / NIA NIH HHS / United States
GM089763 / GM / NIGMS NIH HHS / United States
BC093630 / BC / NCI NIH HHS / United States
CA177910 / CA / NCI NIH HHS / United States
R01 CA177910 / CA / NCI NIH HHS / United States
R01 GM089763 / GM / NIGMS NIH HHS / United States
U54CA143798 / CA / NCI NIH HHS / United States